市場調査レポート

商品コード

1619281

DNAシーケンスの市場規模、シェア、成長分析、製品・サービス別、技術別、ワークフロー別、用途別、最終用途別、地域別- 産業予測、2024～2031年

DNA Sequencing Market Size, Share, Growth Analysis, By Product & Service (Instruments, Consumables), By Technology, By Workflow, By Application, By End-use, By Region - Industry Forecast 2024-2031

出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

DNAシーケンスの世界市場規模は2022年に105億米ドルと評価され、2023年の122億9,000万米ドルから2031年には440億米ドルに成長し、予測期間（2024～2031年）のCAGRは17.12%で成長する見通しです。

米国のDNAシーケンス市場は、次世代および全ゲノム解析技術の急速な進歩に後押しされ、力強い成長が見込まれています。イルミナのNGSのようなイノベーションは、並列処理機能によってシーケンスのスループットとスピードを大幅に向上させ、複数のDNAセグメントの同時解析を可能にすることで、ゲノミクスに革命をもたらしました。このようなデータ処理の高速化により、研究者やヘルスケア専門家は、診断や個別化医療のために重要な遺伝的洞察を効率的に引き出すことができます。この傾向を示すものとして、イルミナは2023年3月に臨床NGSデータ処理を効率化するConnected Insightsクラウドベースプログラムを開始しました。ゲノム研究と個別化医療への関心が高まるにつれ、DNAシーケンスはヘルスケアにおける不可欠なツールとして登場し、診断、治療戦略、疾病予防における有望な進展への道を切り開いています。

市場概要
サンガーシーケンス
次世代シーケンシング
- 全ゲノム配列解析（WGS）
- 全エクソーム配列解析（WES）
- ターゲットシーケンシングとリシーケンシング
第三世代シーケンシング
- 単一分子リアルタイムシーケンシング（SMRT）
- ナノポアシーケンシング

DNAシーケンスの市場規模：ワークフロー別& CAGR（2024-2031）

市場概要
プレシーケンシング
シーケンシング
データ分析

DNAシーケンスの市場規模：用途別& CAGR（2024-2031）

市場概要
腫瘍学
リプロダクティブヘルス
臨床研究
アグリゲノミクスと法医学
HLAタイピング/免疫システムモニタリング
メタゲノミクス、疫学、医薬品開発
消費者ゲノミクス
その他

DNAシーケンスの市場規模：最終用途別& CAGR（2024-2031）

市場概要
学術研究
臨床研究
病院・クリニック
製薬・バイオテクノロジー企業
その他のユーザー

DNAシーケンスの市場規模：地域別& CAGR（2024-2031）

北米
- 米国
- カナダ
欧州
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021-2023）

主要企業プロファイル

Illumina, Inc.
Thermo Fisher Scientific
Pacific Biosciences（PacBio）
Oxford Nanopore Technologies
Qiagen
Agilent Technologies
Bio-Rad Laboratories
PerkinElmer
Element Biosciences
MGI（BGI Group）
Genewiz
Macrogen
OncoDNA
Hamilton Thorne
DNASTAR
Eurofins GATC Biotech
Roche Diagnostics
Wasatch BioLabs
Integrated DNA Technologies（IDT）
Genomatic AG

結論と推奨事項

Product Code: SQSG35H2013

Global DNA Sequencing Market size was valued at USD 10.5 billion in 2022 and is poised to grow from USD 12.29 billion in 2023 to USD 44 billion by 2031, growing at a CAGR of 17.12% in the forecast period (2024-2031).

The US DNA sequencing market is set for robust growth, fueled by rapid advancements in Next-Generation and Whole-Genome Sequencing technologies. Innovations like Illumina's NGS have revolutionized genomics by significantly enhancing sequencing throughput and speed through parallel processing capabilities, enabling the analysis of multiple DNA segments simultaneously. This acceleration in data processing empowers researchers and healthcare professionals to extract critical genetic insights for diagnostics and personalized medicine effectively. Illustrating this trend, Illumina launched its Connected Insights cloud-based program in March 2023 to streamline clinical NGS data processing. As interest in genomic research and personalized medicine grows, DNA sequencing emerges as an indispensable tool in healthcare, paving the way for promising advancements in diagnostics, therapeutic strategies, and disease prevention.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dna Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dna Sequencing Market Segmental Analysis

Global DNA Sequencing Market is segmented by Product & Service, Technology, Workflow, Application, End-use and region. Based on Product & Service, the market is segmented into Consumables, Instruments, Services. Based on Technology, the market is segmented into Sanger Sequencing, Next-Generation Sequencing, Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing & Resequencing, Third Generation Sequencing, Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing. Based on Workflow, the market is segmented into Grade. Based on Application, the market is segmented into Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Consumer Genomics, Others. Based on End-use, the market is segmented into Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dna Sequencing Market

The primary catalyst propelling the DNA sequencing market is the increasing emphasis on personalized therapy. As modern healthcare shifts towards customized treatments, comprehensive genetic information becomes essential. DNA sequencing enables healthcare providers to tailor therapies to individual genetic profiles, enhancing treatment effectiveness while minimizing adverse effects. This demand is particularly pronounced in the oncology field, where precision medicine relies on genetic insights to inform targeted therapies. The rising application of genomics in clinical practices fuels market growth as healthcare systems prioritize precision medicine to improve patient outcomes, thereby driving the need for advanced sequencing technologies and services.

Restraints in the Global Dna Sequencing Market

The global DNA sequencing market is hindered by several constraints, primarily involving the significant costs associated with infrastructure and resource requirements. Despite a general decline in sequencing costs over time, many research institutions and healthcare providers, particularly in underdeveloped nations, encounter substantial challenges in acquiring the essential reagents, advanced equipment, and skilled personnel needed for effective sequencing operations. Moreover, the financial burden of data processing and storage can further escalate operational expenses. These economic limitations often restrict the implementation of cutting-edge sequencing technologies, particularly within smaller laboratories or facilities, thereby adversely affecting industry growth and limiting access to advanced genomic solutions.

Market Trends of the Global Dna Sequencing Market

The Global DNA Sequencing market is witnessing a significant trend towards the integration of artificial intelligence (AI) and machine learning (ML) technologies, focusing on enhancing data analysis and interpretation capabilities. These advanced algorithms are poised to accelerate genomic data processing, allowing researchers to extract valuable insights from complex datasets with unprecedented speed and accuracy. This shift is particularly impactful in personalized medicine and clinical diagnostics, where the demand for swift and precise genetic information is growing. As AI and ML continue to evolve, they are expected to drive innovation in DNA sequencing applications, ultimately transforming healthcare into a more data-driven landscape that caters to individualized patient needs.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies
Customer & Buying Criteria Analysis

Global DNA Sequencing Market Size by Product & Service & CAGR (2024-2031)

Market Overview
Consumables
Instruments
Services

Global DNA Sequencing Market Size by Technology & CAGR (2024-2031)

Market Overview
Sanger Sequencing
Next-Generation Sequencing
- Whole Genome Sequencing (WGS)
- Whole Exome Sequencing (WES)
- Targeted Sequencing & Resequencing
Third Generation Sequencing
- Single-Molecule Real-Time Sequencing (SMRT)
- Nanopore Sequencing

Global DNA Sequencing Market Size by Workflow & CAGR (2024-2031)

Market Overview
Pre-sequencing
Sequencing
Data Analysis

Global DNA Sequencing Market Size by Application & CAGR (2024-2031)

Market Overview
Oncology
Reproductive Health
Clinical Investigation
Agrigenomics & Forensics
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Consumer Genomics
Others

Global DNA Sequencing Market Size by End-use & CAGR (2024-2031)

Market Overview
Academic Research
Clinical Research
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other Users

Global DNA Sequencing Market Size & CAGR (2024-2031)

North America, (Product & Service, Technology, Workflow, Application, End-use)
- US
- Canada
Europe, (Product & Service, Technology, Workflow, Application, End-use)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product & Service, Technology, Workflow, Application, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product & Service, Technology, Workflow, Application, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product & Service, Technology, Workflow, Application, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Illumina, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences (PacBio)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Element Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MGI (BGI Group)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genewiz
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Macrogen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OncoDNA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Thorne
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DNASTAR
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins GATC Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wasatch BioLabs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies (IDT)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genomatic AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments